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Specimen Shrinkage and Its Influence on 
Margin Assessment in Breast Cancer
Badrul H. Yeap, Suseela Muniandy, Suk-Kam Lee, Subathra Sabaratnam and Manjit Singh, Department of
General Surgery, Penang General Hospital, Penang, Malaysia.
OBJECTIVE: The determination of tumour-free margin in breast cancer is crucial in deciding subse-
quent patient management. To exemplify the phenomenon of margin contraction during specimen
preparation for histopathological analysis, we quantified the shrinkage of breast specimens as a result of
formalin fixation.
METHODS: Fifty consecutive mastectomy and wide excision specimens were prospectively appraised.
The closest free margin and maximal tumour diameter of fresh, unprepared specimens were recorded.
These measurements were compared with the corresponding parameters following tissue fixation.
RESULTS: Following formalin fixation, the mean closest free margin of the specimens was found to have
decreased from 10.28 mm to 6.78 mm (34%). The reduction of the mean diameter of the tumour itself
was less significant, from 41.74 mm to 39.88 mm (4.5%).
CONCLUSION: Breast specimens undergo shrinkage after histological fixation, losing more than a
third of their original closest free margin, whilst the tumour itself does not shrink substantially. This
phenomenon has vital implications in the accuracy of margin analysis and consequent decisions on 
further management, including re-operation and the institution of adjuvant radiotherapy. [Asian J Surg
2007;30(3):183–7]
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Introduction
As with most malignancies, the assessment of tumour-
free margin is vital in establishing the adequacy of surgery
for patients with breast cancer.1 Postoperative treatment
options are significantly influenced by this single param-
eter. With the paradigm shift in breast oncology towards
breast-conserving surgery,2 the margin factor has assumed
added importance. In general, patients with positive or
involved surgical margins are offered additional surgery
(either wider excision or mastectomy), patients with
“close” margins are treated either with additional surgery
or external beam radiotherapy, and patients with negative
margins undergo postoperative radiotherapy.2–4 Even
after a total mastectomy, patients with close margins are
usually advised to receive a directed boost of radiotherapy
to the tumour bed.3 Furthermore, margin status has
emerged as the strongest predictor of local recurrence in
breast-conserving surgery.5,6
It has been well established that following histological
fixation, there is considerable specimen shrinkage which
diminishes the eventual tumour-free margin, with tissues
fixed in formaldehyde and embedded in paraffin wax
shrinking by about 33%.7 Despite a comprehensive MED-
LINE search from 1960 to 2006, there is no literature
report of the exact degree of shrinkage of breast cancer
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specimens. We therefore decided to prospectively quan-
tify the differences in tumour-free margins due to the
process of specimen fixation. The initiative for undertak-
ing this detailed measurement was also incited by our
experience with a cohort of patients who underwent
breast-conserving surgery at our institution. These
patients were initially reported to have either positive 
or close margins as defined by the Malaysian consensus,3
but ensuing wider excision or mastectomy revealed no
residual tumour. Though it is acknowledged that surgery
induces tissue destruction and inflammation that may
cause tumours within a few millimetres to be destroyed,
we hypothesize that additional factors such as the process
of specimen fixation may further consolidate and shrink
breast tissue to a degree that is significant enough to
influence subsequent treatment decisions.
Patients and methods
Between November 2003 and January 2005, all suitable
patients undergoing mastectomy and wide local excision
for breast cancer were recruited into this study. The study
protocol was fully approved by the hospital’s ethics com-
mittee, and the project was carried out in accordance with
good clinical practice guidelines as endorsed by the
Ministry of Health, Malaysia. Written informed consent
was obtained from patients, and their anonymity was
safeguarded throughout the study.
Exclusion criteria were T4 tumours and specimens
from patients who had undergone prior downstaging
chemotherapy. Only margins with extensive8 tumour
involvement were analysed; margins that were graded as
focal, minimal or moderate extent of positivity8 were
omitted from analysis. Additional data recorded included
patient age, tumour grade, stage of the disease, type of
surgery, and final tumour histology.
Immediately after excision, the breast specimens were
delivered fresh without immersion in formalin to the
pathologist who then prepared them according to the
accepted protocol.9 Wide excision specimens were sec-
tioned into 3–4 mm slices, whilst mastectomy specimens
were cut longitudinally from their posterior aspect into
slices approximately 2 cm thick. All margins as well as 
the maximal tumour diameters were then measured to
the nearest millimetre. The pathologist was always alerted
of an imminent specimen at the commencement of each
breast operation; thus, the entire process of pre-fixation
measurement was confined to within 10 minutes of its
removal. Specimens were subsequently fully immersed in
the prescribed volume of fixative, i.e. the ratio of 10% for-
malin to tissue approximated 10:1. The corresponding
measurements were then recorded by the same patholo-
gist the following morning, as is the standard practice at
our laboratory.
The disparity of the closest free margins and the maxi-
mal tumour diameters were compared using paired t test
analysis (Stata version 8.2; Stata Corp., College Station,
TX, USA) and differences were considered significant
when p < 0.05. The power of this study was calculated to
exceed 90%.
Results
Fifty consecutive patients corresponding to 200 measure-
ments were recorded. The median age was 57 years (range,
32–84 years). All tumours were confirmed to be infiltrat-
ing ductal carcinoma. Most (90%) of the specimens came
from mastectomies, whilst the rest were from wide local
excisions. All patients underwent at least a level II axillary
clearance. Nodal involvement was present in more than
half of the patients. The majority of tumours were grade
3 (44%), while grades 2 and 1 tumours constituted 42%
and 14% of the specimens, respectively. Tumours were
also relatively large, with 58% T2, 40% T3 and only 2% T1
tumours.
The distribution of data for pre- and post-fixation
closest free margins is shown by the box plots in Figure 1.
There was margin reduction post fixation as demonstrated
by their respective median values, i.e. 7.0 mm before fixa-
tion compared to 3.5 mm post fixation. In contrast, the
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Figure 1. Pre- and post-fixation closest free margins (mm).
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box plots representing tumour diameters both reveal
median values of 35 mm (Figure 2).
As shown in the Table, the mean closest free margin
before fixation was 10.28 ± 10.53 mm (range, 1–60 mm),
whilst the mean margin after fixation was 6.78 ± 7.98 mm
(range, 0–40 mm). This reduction was statistically sig-
nificant (p < 0.0001). There was thus an average of 3.5 mm
(34%) loss of margin following fixation. Conversely, 
the mean maximal tumour diameter of breast specimens
before fixation was 41.74 ± 18.63 mm (range, 18–120 mm),
whilst the mean diameter post fixation was 39.88 ±
17.65 mm (range, 10–95 mm). This difference of 1.86 mm
(4.5%) was not, however, statistically significant (p = 0.112).
Every specimen showed margin shrinkage, which
ranged from 6% to 93%. While mastectomy specimens
demonstrated an average margin reduction of 33%, the
mean shrinkage of wide excision margins was even more
appreciable, at approximately 58%.
Discussion
With more breast-conserving surgery being performed for
both in situ and invasive breast cancers, margin status is
increasingly crucial in determining the outcome of ther-
apy. Recent studies10,11 have firmly established a signifi-
cantly higher rate of local recurrence for breast cancers
with positive microscopic margins compared to those
with negative margins. The rate of residual tumour in
specimens with positive margins ranged between 17% and
56%,12,13 in contrast to no residual tumour in our earlier
observation. Recurrence is also dependent on the degree
of margin involvement, being higher in patients with
extensive margin involvement than in those with focal or
limited margin involvement.14,15
Yet there are many intricacies in the science that is
margin evaluation. The most startling is the lack of uni-
versal agreement on margin definition. Despite the broad
adoption of breast-conserving therapy, there exists signif-
icant variation in the perception of negative and close
margins among pathologists and radiation oncologists.15
For example, the US Joint Center for Radiation Therapy
defines a close margin as < 1 mm and a negative margin 
as > 1 mm,16 whilst the Radiotherapy and Oncology 
Consensus, Hospital Kuala Lumpur,3 which formulates
the Malaysian radiotherapy guidelines for breast cancer
defines a close margin as between 5 and 10 mm and a neg-
ative margin as > 10 mm. Next, several technical difficul-
ties have been acknowledged. Despite their posthaste
delivery to the pathologist, some amount of specimen
compression will be inevitable as specimens are not sus-
pended in their transport container. From the patholo-
gist’s point of view, the large and complex surface of most
breast specimens makes margin assessment imperfect.17
Notwithstanding the success of breast conservation being
heavily reliant on the quality of the pathological service,
variation in margin assessment is known to exist among
pathologists.18 Finally, there is no clear consensus regard-
ing the ideal margin after wide local excision,15 even with
the overwhelming evidence and existing guidelines for
breast-conserving therapy.
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Table. Measurements of the closest free margins and maximal tumour diameters in relation to specimen fixation
Pre fixation Post fixation Mean difference
Mean closest free margin (mm) 10.28 6.78 3.5*
95% CI = 2.28–4.72
Mean maximal tumour diameter (mm) 41.74 39.88 1.86†
95% CI = 1.17–4.90
*p< 0.0001; †p = 0.112. CI = confidence interval.
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Figure 2. Pre- and post-fixation maximal tumour diameters (mm).
The study cohort was recruited to reflect a cross sec-
tion of our typical breast cancer patients, of which indige-
nous factors contribute to the preponderance of higher 
T stage and grade of the disease.19 Thus, mastectomy
specimens predominate even though the inference from
this trial would probably best benefit patients undergo-
ing wide local excisions. The effect of specimen fixation
on mastectomy specimens was nonetheless explored on
the premise that the outcome could influence the deci-
sion of whether to institute adjuvant treatment, namely
postoperative radiotherapy, to the breast bed.
The period of specimen fixation is a balance between
sufficient penetration of fixatives and prevention of sec-
ondary shrinkage and excessive hardening of tissue.20
This study adhered to our standard laboratory protocol9
of histological examination the following day, i.e. over-
night fixation, although 6–8 hours may be sufficient. With
the specimen entirely sliced, and standardized specimen-
to-formalin ratio ensuring maximal exposure to the 
fixative, the proportion of margin shrinkage was deemed
comparable irrespective of pre-fixation tissue volume.
The comparison of pre-fixation macroscopic margin
to post-fixation microscopic margin in principle may be
considered incompatible. However, this is quite possibly
the most feasible and practical method of documenting
and quantifying shrinkage due to specimen fixation, as
attested by previous similar studies involving colorectal21
and oesophageal22 specimens. This analysis attempted to
equate the two margins as accurately as possible by only
considering margins with extent of positivity8 graded
“extensive”, whilst lesser grades of margin involvement
were disregarded. Moreover, particular attention was paid
to closest margin, although all margins were recorded in
view of its clinical significance in the determination of
additional surgery or adjuvant therapy.
Nevertheless, specimen shrinkage in this study was
striking and mainly in the form of tumour-free margin
while the tumour itself did not shrink substantially. The
explanation may be due to the degradation of lipid to their
water-soluble derivatives by formaldehyde, thus effectively
dehydrating the fat margin.23 This conjecture could explain
the absence of residual tumour in the re-excision specimens
from our earlier observation, as well as elucidate the discrep-
ancy between the specimen dimensions as measured by the
pathologist and those perceived by the surgeon frequently
encountered at our multidisciplinary breast conference.
While colorectal21 and oesophageal22 specimens have been
shown to lose at least half of their margins, it is believed
that this is the first study to quantify the degree of breast
specimen shrinkage as a result of formalin fixation. It may
not be of that much concern in colorectal or oesophageal
malignancies, but in breast, millimetres matter.
Specimen shrinkage may therefore cause the margins
to appear spuriously involved with tumour and therefore
classified as positive. The implications of this margin
aberration are far reaching and can potentially alter the
current guidelines on further surgery as well as adjuvant
therapy. It may result in unnecessary surgery, either 
a wider excision or mastectomy after breast-conserving
surgery for margins that are incorrectly classified as posi-
tive. A case in point: a margin of 5 mm in a fresh, unpre-
pared specimen that undergoes shrinkage post fixation of
the degree observed in this study would mean an average
final reported margin of 1.7 mm. Some authorities would
recommend wider excision or mastectomy based on this
“close” surgical margin.2–4 As far as the local guidelines are
concerned, this qualifies as a major criterion for adjuvant
radiotherapy.3 Unnecessary expenditure aside, the inherent
morbidity24 and even mortality25 associated with additional
surgery or adjuvant therapy is hardly inconsequential.
In summary, the margin loss in breast cancer speci-
mens due to tissue fixation is quite dramatic. In response
to this phenomenon, several recommendations are prof-
fered. Firstly, with such diverse interpretation,15 a univer-
sal definition of margin is urgently required as a means 
of recommending re-excision and comparing treatment
results. Next, techniques such as specimen suspension
during transport and fixation could be initiated to miti-
gate specimen handling errors.
It must be emphasized that our current practice with
regards to breast cancers with involved margins cannot as
yet be changed, as we are unable to differentiate margins
that are truly positive from those that are spuriously posi-
tive. Nevertheless, these preliminary findings have helped
to establish a local benchmark for breast specimen
shrinkage, apart from stimulating a new prospective ran-
domized trial comparing the outcome of treatment based
exclusively on pre- and post-fixation margins.
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